Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01908751 · ClinicalTrials.gov registry record · Phase 3
Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)
A Phase 3 study, sponsored by McMaster University.
- Terminated
- Registry status
- Phase 3
- Development phase
- 91
- Enrollment target
NCT01908751: Clinical Trial Phase 3 study, sponsored by McMaster University.
NCT01908751 is a Phase 3 study that was terminated before completion, run by McMaster University. The registered enrollment target is 91 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01908751, a Phase 3 study, was terminated before completion, sponsored by McMaster University.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 91 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of surgical fixation (cancellous screws versus sliding hip screws) and biologic intervention (Vitamin D versus placebo) on patient important outcomes.
Primary Outcome
A participant met the primary clinical endpoint if they experienced one or more of the four outcomes: 1. Re-operation: any unplanned surgery related to the treatment of the femoral neck fracture; 2. Femoral head osteonecrosis: any evidence of osteonecrosis on any follow-up medical imaging study (i.e., radiographs, magnetic resonance imaging (MRI), or other advanced imaging study); 3. Severe femoral neck malunion: fracture healing with femoral neck shortening of \>10 mm in any plane on follow-up
Interventions
- DRUG Vitamin D
- PROCEDURE Sliding Hip Screw
- PROCEDURE Cancellous Screws
- DRUG Vitamin D Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 91 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-03-18 |
| Phase | Phase 3 |
Why NCT01908751 stopped before completion
NCT01908751 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 91 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Vitamin D is the first listed.
NCT01908751 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01908751 about?
NCT01908751 is a clinical study titled "Fixation Using Alternative Implants for the Treatment of Hip Fractures (FAITH-2)". The purpose of this study is to determine the impact of surgical fixation (cancellous screws versus sliding hip screws) and biologic intervention (Vitamin D versus placebo) on patient important outcomes.
What is the current status of trial NCT01908751?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 91 participants. The study started on 2014-09. Estimated completion is 2019-03-18.
What interventions are being tested in trial NCT01908751?
The interventions under investigation include: Vitamin D (DRUG), Sliding Hip Screw (PROCEDURE), Cancellous Screws (PROCEDURE), Vitamin D Placebo (DRUG).
Who is sponsoring clinical trial NCT01908751?
This trial is sponsored by McMaster University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01908751's enrollment target sits among peer trials
91 1724th of 2000 higher than 277 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02671448 · 91 participants · NA
Pilot Trial of Homebound Stem Cell Transplantation
- NCT04835857 · 91 participants
Comparison of Cuff-Less Wrist Wearable Blood Pressure Device to Cuff Based Blood Pressure Measuring Devices
- NCT05184842 · 91 participants · Phase 2
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML
- NCT05685173 · 91 participants · Phase 1
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia